These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29675687)
1. Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients. Wu X; Xu W; Wang J; Tian X; Tian Z; Xu K Front Med; 2019 Apr; 13(2):259-266. PubMed ID: 29675687 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients. Cottin V; Harari S; Humbert M; Mal H; Dorfmüller P; Jaïs X; Reynaud-Gaubert M; Prevot G; Lazor R; Taillé C; Lacronique J; Zeghmar S; Simonneau G; Cordier JF; Eur Respir J; 2012 Sep; 40(3):630-40. PubMed ID: 22362861 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis. Hua W; Yang W; Gu J; Wu J; Wang W; Liu Y; Zhu H; Zhou M; Qu J; Fang Y Int J Cardiovasc Imaging; 2021 Feb; 37(2):439-448. PubMed ID: 32929608 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method. Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470 [TBL] [Abstract][Full Text] [Related]
6. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study. Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386 [TBL] [Abstract][Full Text] [Related]
7. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis. Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K; Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460 [TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis. Hu S; Wu X; Xu W; Tian X; Yang Y; Wang ST; Liu S; Xu X; Xu KF Orphanet J Rare Dis; 2019 Aug; 14(1):206. PubMed ID: 31429781 [TBL] [Abstract][Full Text] [Related]
9. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis. Crausman RS; Lynch DA; Mortenson RL; King TE; Irvin CG; Hale VA; Newell JD Chest; 1996 Jan; 109(1):131-7. PubMed ID: 8549175 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography. Sonaglioni A; Baravelli M; Cassandro R; Torre O; Elia D; Anzà C; Harari S J Am Soc Echocardiogr; 2018 Aug; 31(8):888-901. PubMed ID: 29605474 [TBL] [Abstract][Full Text] [Related]
11. Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension. Wierzbowska-Drabik K; Kasprzak JD; D Alto M; Ágoston G; Varga A; Ferrara F; Amor M; Ciampi Q; Bossone E; Picano E Int J Cardiovasc Imaging; 2020 Oct; 36(10):1831-1843. PubMed ID: 32462450 [TBL] [Abstract][Full Text] [Related]
12. Cyst Ventilation Heterogeneity and Alveolar Airspace Dilation as Early Disease Markers in Lymphangioleiomyomatosis. Walkup LL; Roach DJ; Hall CS; Gupta N; Thomen RP; Cleveland ZI; McCormack FX; Woods JC Ann Am Thorac Soc; 2019 Aug; 16(8):1008-1016. PubMed ID: 31038987 [No Abstract] [Full Text] [Related]
13. Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study. de Lima-Filho NN; Figueiredo MS; Vicari P; Cançado R; Carvalho AC; Bordin JO; Campos O Echocardiography; 2016 Dec; 33(12):1880-1890. PubMed ID: 25521187 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis. Diesler R; Cottin V; Gallien Y; Turquier S; Traclet J; Ahmad K; Glerant JC Respir Med Res; 2024 Jun; 85():101071. PubMed ID: 38141576 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. McCormack FX; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Young LR; Kinder BW; Downey GP; Sullivan EJ; Colby TV; McKay RT; Cohen MM; Korbee L; Taveira-DaSilva AM; Lee HS; Krischer JP; Trapnell BC; ; N Engl J Med; 2011 Apr; 364(17):1595-606. PubMed ID: 21410393 [TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors]. Wang T; Mao Y; Sun Y; Hou W; Feng Y; Qu H Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1037-40. PubMed ID: 26887371 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis. Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J Chest; 2018 Jan; 153(1):124-132. PubMed ID: 28533049 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis. Steagall WK; Stylianou M; Pacheco-Rodriguez G; Moss J JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843885 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis. Yoon HY; Hwang JJ; Kim DS; Song JW Orphanet J Rare Dis; 2018 Nov; 13(1):204. PubMed ID: 30428897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]